Tom Henderson
- Delphinus Medical Technologies Inc. is about to graduate. And, after 17 years of research and development and three rounds of venture capital totaling $58.5 million, it will start selling its first devices for ultrasonic detection of breast cancer. Delphinus has been a tenant since 2010 in the Plymouth Township-based Michigan Life Science and Innovation Center, a tech incubator in a former Pfizer Inc. facility that is owned by the Michigan Economic Development Corp. According to Mark Forchette,
Tom Henderson
- Delphinus Medical Technologies Inc. is about to graduate. And, after 17 years of research and development and three rounds of venture capital totaling $58.5 million, it will start selling its first devices for ultrasonic detection of breast cancer. Delphinus has been a tenant since 2010 in the Plymouth Township-based Michigan Life Science and Innovation Center, a tech incubator in a former Pfizer Inc. facility that is owned by the Michigan Economic Development Corp. According to Mark Forchette,